Search Results - Zhanjing Dai

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    The cost-effectiveness of iruplinalkib versus alectinib in anaplastic lymphoma kinase-positive crizotinib-resistant advanced non-small-cell lung cancer patients in China by Zhanjing Dai, Jiayi Xu, Feng Chang, Wanxin Zhou, Ting Ren, Jiaxin Qiu, Yun Lu, Yuqiong Lu

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: